Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent advances in vaccine development for herpes simplex virus types I and II

20 Feb 2013

Abstract excerpt

Despite recent advances in vaccine design and strategies, latent infection with herpes simplex virus (HSV) remains a formidable challenge. Approaches involving live-attenuated viruses and inactivated viral preparations were popular throughout the twentieth century. In the past ten years, many vaccine types, both prophylactic or therapeutic, have contained a replication-defective HSV, viral DNA or glycoproteins....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Immunotherapy and Immune Responses
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23442925
DOI: 10.4161/hv.23289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent advances in vaccine development for herpes simplex virus types I and IIPMID 23442925Read ↗

Immunization against genital herpes with a vaccine virus that has defects in productive and latent infectionSemantic proximity Read ↗

The Quest for Immunity: Exploring Human Herpesviruses as Vaccine VectorsSemantic proximity Read ↗

Toward the Eradication of Herpes Simplex Virus: Vaccination and BeyondSemantic proximity Read ↗

Herpes Simplex Virus Evasion of Early Host Antiviral ResponsesSemantic proximity Read ↗

Herpes Simplex Virus: A Versatile Tool for Insights Into Evolution, Gene Delivery, and Tumor ImmunotherapySemantic proximity Read ↗

Medical application of herpes simplex virus.Semantic proximity Read ↗

Clinical management of herpes simplex virus infections: past, present, and futureSemantic proximity Read ↗

A Live-Attenuated HSV-2 ICP0− Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit VaccineSemantic proximity Read ↗

Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease.Semantic proximity Read ↗

Glycoprotein targeted therapeutics: a new era of anti‐herpes simplex virus‐1 therapeuticsSemantic proximity Read ↗

Gender-Dependent HLA-DR-Restricted Epitopes Identified from Herpes Simplex Virus Type 1 Glycoprotein DSemantic proximity Read ↗

Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.